化疗相关性血栓形成的处理方法
Approach to chemotherapy-associated thrombosis.
作者信息
Oppelt Peter, Betbadal Anthony, Nayak Lalitha
机构信息
Case Western Reserve University, Cleveland, OH, USA
Case Western Reserve University, Cleveland, OH, USA.
出版信息
Vasc Med. 2015 Apr;20(2):153-61. doi: 10.1177/1358863X14568705.
Abstract
Treatment of cancer patients with antineoplastic agents is associated with a heightened risk of thrombotic events, both arterial and venous. In this article, we review the specific agents that are implicated and the pathophysiological processes that are known to be associated with this prothrombotic state. We conclude with current recommendations for prophylactic antithrombotic therapy in these clinical situations.
摘要
使用抗肿瘤药物治疗癌症患者会增加动脉和静脉血栓形成事件的风险。在本文中，我们回顾了与之相关的特定药物以及已知与这种血栓前状态相关的病理生理过程。最后，我们给出了在这些临床情况下预防性抗血栓治疗的当前建议。
相似文献
1
Approach to chemotherapy-associated thrombosis.
Vasc Med. 2015 Apr;20(2):153-61. doi: 10.1177/1358863X14568705.
2
[The prevention and treatment of pulmonary embolism in cancer].
Rev Prat. 2007 Apr 15;57(7):738-9.
3
[Cancer and venous thromboembolism].
Rev Mal Respir. 2011 Apr;28(4):443-52. doi: 10.1016/j.rmr.2011.02.007. Epub 2011 Mar 22.
4
The treatment of venous thromboembolic disorders: new challenges and opportunities.
Haematologica. 2003 Jun;88(6):610-3.
5
Thromboembolism in cancer patients: pathogenesis and treatment.
Clin Appl Thromb Hemost. 2006 Jul;12(3):254-66. doi: 10.1177/1076029606291432.
6
[Venous thromboembolism and cancer].
Arch Mal Coeur Vaiss. 2001 Nov;94(11 Suppl):1307-12.
7
Thromboprophylaxis during chemotherapy in patients with advanced cancer.
Thromb Res. 2010 Apr;125 Suppl 2:S17-20. doi: 10.1016/S0049-3848(10)70007-4.
8
Thrombosis: the relationship of hemostatic mechanisms to drug therapy.
J Neurosurg. 1981 Jan;54(1):1-11. doi: 10.3171/jns.1981.54.1.0001.
9
[Venous thromboembolism and cancer].
Rev Prat. 2015 Feb;65(2):216-9.
10
Venous thromboembolism in the ICU and reversal of bleeding on anticoagulants.
Crit Care Clin. 2005 Jul;21(3):497-512. doi: 10.1016/j.ccc.2005.05.004.
引用本文的文献
1
A pharmacovigilance study of thromboembolism events associated with vascular endothelial growth factor receptor tyrosine kinase inhibitors based on FAERS database.
Sci Rep. 2025 Jul 11;15(1):25120. doi: 10.1038/s41598-025-11067-x.
2
Incidental venous thrombosis in oncology in a sub-Saharan tertiary hospital.
Ecancermedicalscience. 2024 Nov 7;18:1793. doi: 10.3332/ecancer.2024.1793. eCollection 2024.
3
The factors affecting the survivability of malignant cancer patients with deep vein thrombosis among subjects with gynecologic and non-gynecologic cancer: An ambispective cohort study.
F1000Res. 2023 Dec 12;12:890. doi: 10.12688/f1000research.135252.2. eCollection 2023.
4
Underlying Mechanisms of Thrombosis Associated with Cancer and Anticancer Therapies.
Curr Treat Options Oncol. 2024 Jul;25(7):897-913. doi: 10.1007/s11864-024-01210-7. Epub 2024 Jun 12.
5
Development and validation of a nomogram model for predicting the risk of venous thromboembolism in lymphoma patients undergoing chemotherapy: a prospective cohort study conducted in China.
Ann Med. 2023;55(2):2275665. doi: 10.1080/07853890.2023.2275665. Epub 2023 Dec 22.
6
Complications of Central Venous Access Devices Used in Palliative Care Settings for Terminally Ill Cancer Patients: A Systematic Review and Meta-Analysis.
Cancers (Basel). 2023 Sep 25;15(19):4712. doi: 10.3390/cancers15194712.
7
How to Treat Today? Oral and Facial Cancer-Associated Venous Thromboembolism.
Pharmaceuticals (Basel). 2023 Jul 17;16(7):1011. doi: 10.3390/ph16071011.
8
Temozolomide and Lomustine Induce Tissue Factor Expression and Procoagulant Activity in Glioblastoma Cells In Vitro.
Cancers (Basel). 2023 Apr 18;15(8):2347. doi: 10.3390/cancers15082347.
9
Reactive myelopoiesis and FX-expressing macrophages triggered by chemotherapy promote cancer lung metastasis.
JCI Insight. 2023 May 8;8(9):e167499. doi: 10.1172/jci.insight.167499.
10
Oral Squamous Cell Carcinoma-Associated Thrombosis: What Evidence?
Cancers (Basel). 2022 Nov 16;14(22):5616. doi: 10.3390/cancers14225616.
本文引用的文献
1
The thromboprotective effect of bortezomib is dependent on the transcription factor Kruppel-like factor 2 (KLF2).
Blood. 2014 Jun 12;123(24):3828-31. doi: 10.1182/blood-2014-01-547448. Epub 2014 Apr 25.
2
Venous thromboembolism in multiple myeloma.
Semin Thromb Hemost. 2014 Apr;40(3):338-47. doi: 10.1055/s-0034-1370793. Epub 2014 Mar 5.
3
Antiangiogenic therapy inhibits venous thrombus resolution.
Arterioscler Thromb Vasc Biol. 2014 Mar;34(3):565-70. doi: 10.1161/ATVBAHA.113.302998. Epub 2014 Jan 16.
4
Pomalidomide alone or in combination with low-dose dexamethasone in relapsed and refractory multiple myeloma: a randomized phase 2 study.
Blood. 2014 Mar 20;123(12):1826-32. doi: 10.1182/blood-2013-11-538835. Epub 2014 Jan 13.
5
Increased PAC-1 expression among patients with multiple myeloma on concurrent thalidomide and warfarin.
Blood Coagul Fibrinolysis. 2013 Dec;24(8):893-5. doi: 10.1097/MBC.0b013e3283642ee2.
6
Biomarkers for prediction of venous thromboembolism in cancer.
Blood. 2013 Sep 19;122(12):2011-8. doi: 10.1182/blood-2013-04-460147. Epub 2013 Aug 1.
7
Venous thromboembolism prophylaxis and treatment in patients with cancer: American Society of Clinical Oncology clinical practice guideline update.
J Clin Oncol. 2013 Jun 10;31(17):2189-204. doi: 10.1200/JCO.2013.49.1118. Epub 2013 May 13.
8
Use of glucocorticoids and risk of venous thromboembolism: a nationwide population-based case-control study.
JAMA Intern Med. 2013 May 13;173(9):743-52. doi: 10.1001/jamainternmed.2013.122.
9
Venous thromboembolic events with vascular endothelial growth factor receptor tyrosine kinase inhibitors: a systematic review and meta-analysis of randomized clinical trials.
Crit Rev Oncol Hematol. 2013 Jul;87(1):80-9. doi: 10.1016/j.critrevonc.2012.12.006. Epub 2013 Jan 12.
10
Endothelial stress products and coagulation markers in patients with multiple myeloma treated with lenalidomide plus dexamethasone: an observational study.
Br J Haematol. 2013 Feb;160(3):351-8. doi: 10.1111/bjh.12152. Epub 2012 Dec 13.
Zotero 插件